Imatinib
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints (NCT01216085) | Novartis Pharmaceuticals | 2010-08-01 |
| Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib (NCT01564836) | Seoul St. Mary's Hospital | 2010-06-01 |
| Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy (NCT01316458) | Novartis Pharmaceuticals | 2003-06-01 |
Track Imatinib automatically
Every clearance here is in the API, with alerts when new ones post.